MISTY MAHAFFEY: Open Payments
NPI 1831569391 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,041 in 48 payments from 17 companies in 2025. Trend: 2023 $701 · 2024 $1,059 · 2025 $2,041
Food & beverage: $2,041
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $381 |
| Janssen Biotech, Inc. | 6 | $306 |
| Syndax Pharmaceuticals, Inc. | 2 | $292 |
| Rigel Pharmaceuticals, Inc. | 6 | $256 |
| Daiichi Sankyo Inc. | 8 | $216 |
| AstraZeneca Pharmaceuticals LP | 7 | $155 |
| BeOne Medicines USA, Inc. | 3 | $83 |
| Geron Corporation | 1 | $66 |
| ABBVIE INC. | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
Products named: REVUFORJ, OPDIVO, Vanflyta, CALQUENCE, RYBREVANT, TAVALISSE, BREYANZI, REZLIDHIA.
Industry payments across CA — which companies pay providers there.
